Brokerages Expect Monsanto (MON) Will Announce Earnings of $2.19 Per Share

Wall Street brokerages expect Monsanto (NYSE:MON) to post earnings of $2.19 per share for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Monsanto’s earnings. The highest EPS estimate is $2.56 and the lowest is $2.05. Monsanto reported earnings per share of $1.93 during the same quarter last year, which would indicate a positive year over year growth rate of 13.5%. The firm is scheduled to report its next earnings report on Wednesday, June 27th.

On average, analysts expect that Monsanto will report full-year earnings of $5.70 per share for the current fiscal year, with EPS estimates ranging from $5.50 to $6.00. For the next financial year, analysts forecast that the business will report earnings of $6.30 per share, with EPS estimates ranging from $5.50 to $7.00. Zacks’ EPS calculations are an average based on a survey of analysts that cover Monsanto.

Get Monsanto alerts:

Monsanto (NYSE:MON) last issued its quarterly earnings results on Thursday, April 5th. The basic materials company reported $3.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.31 by ($0.09). Monsanto had a return on equity of 37.31% and a net margin of 17.07%. The firm had revenue of $5.02 billion for the quarter, compared to analyst estimates of $5.34 billion. During the same quarter last year, the firm earned $3.19 earnings per share. The company’s revenue was down 1.1% compared to the same quarter last year.

MON has been the topic of a number of research analyst reports. ValuEngine raised shares of Monsanto from a “hold” rating to a “buy” rating in a report on Monday, April 9th. Wells Fargo reissued a “market perform” rating and set a $128.00 price objective (up previously from $118.00) on shares of Monsanto in a report on Wednesday, January 17th. Deutsche Bank reissued a “buy” rating on shares of Monsanto in a report on Tuesday, January 16th. Argus downgraded shares of Monsanto from a “buy” rating to a “sell” rating in a report on Monday, April 16th. Finally, BMO Capital Markets downgraded shares of Monsanto from an “outperform” rating to a “market perform” rating in a report on Tuesday, April 10th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the company. Monsanto has an average rating of “Hold” and an average price target of $126.61.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Gradient Investments LLC purchased a new stake in shares of Monsanto in the fourth quarter valued at about $108,000. Bruderman Asset Management LLC purchased a new stake in shares of Monsanto in the first quarter valued at about $114,000. Private Capital Group LLC lifted its holdings in shares of Monsanto by 1,663.4% in the first quarter. Private Capital Group LLC now owns 1,252 shares of the basic materials company’s stock valued at $146,000 after purchasing an additional 1,181 shares in the last quarter. Elkfork Partners LLC purchased a new stake in shares of Monsanto in the fourth quarter valued at about $162,000. Finally, Truewealth LLC purchased a new stake in shares of Monsanto in the fourth quarter valued at about $163,000. 75.13% of the stock is currently owned by institutional investors.

Shares of Monsanto stock traded up $0.15 on Wednesday, reaching $125.44. 2,734,474 shares of the stock were exchanged, compared to its average volume of 3,670,059. The firm has a market cap of $55.08 billion, a price-to-earnings ratio of 22.81, a price-to-earnings-growth ratio of 2.58 and a beta of 0.95. Monsanto has a 1-year low of $125.15 and a 1-year high of $125.50. The company has a quick ratio of 0.85, a current ratio of 1.41 and a debt-to-equity ratio of 0.85.

Monsanto Company Profile

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds under the DEKALB, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands.

Get a free copy of the Zacks research report on Monsanto (MON)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Monsanto (NYSE:MON)